Pityriasis rosea developing after COVID-19 vaccination.

Marcantonio-Santa Cruz, O Y; Vidal-Navarro, A; Pesqué, D; Giménez-Arnau, A M; Pujol, R M; Martin-Ezquerra, G

Marcantonio-Santa Cruz, O Y; Vidal-Navarro, A; Pesqué, D; Giménez-Arnau, A M; Pujol, R M; Martin-Ezquerra, G.

Marcantonio-Santa Cruz OY; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
Vidal-Navarro A; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
Pesqué D; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
Giménez-Arnau AM; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
Pujol RM; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
Martin-Ezquerra G; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.

J Eur Acad Dermatol Venereol ; 35(11): e721-e722, 2021 Nov.

Article in English | MEDLINE | ID: covidwho-1301507

Subject(s)

COVID-19; Pityriasis Rosea; COVID-19 Vaccines; Humans; Pityriasis Rosea/etiology; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Rosea / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.17498

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google